Hypotestosteronemia in chronically critically ill men

Critical Care Medicine

Volumn 27, Issue 11, 1999, Pages 2418-2421

  Nierman, David M ^a,b   Mechanick, Jeffrey I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Adult; Aged; Chronic disease; Critical illness rehabilitation; Prevalence; Risk factors; Testosterone, blood; Testosterone, deficiency; Ventilator weaning

Indexed keywords

DOPAMINE; TESTOSTERONE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CRITICAL ILLNESS; HUMAN; INTENSIVE CARE UNIT; MALE; NUTRITIONAL SUPPORT; PREVALENCE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

EID: 0032732358     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199911000-00016     Document Type: Article

References (33)

1. 1. Wang C, Chan V, Yeung RTT: Effect of surgical stress on pituitary-testicular function. Clin Endocrinol 1978; 9:249-253
2. 2. Dong Q, Hawker F, McWilliam D, et al: Circulating immunoreactive inhibin and testosterone levels in men with critical illness. Clin Endocrinol 1992; 36:399-404
3. 3. Vogel AV, Peake GT, Rada RT: Pituitary-testicular axis dysfunction in burned men. J Clin Endocrinol Metab 1985; 60:658-665
4. 4. Luppa P, Munker R, Nagel D, et al: Serum androgens in intensive-care patients: Correlations with clinical findings. Clin Endocrinol 1991; 34:305-310
5. 5. Woolf PD, Hamill RW, McDonald JV, et al: Transient hypogonadotropic hypogonadism is caused by critical illness. J Clin Endocrinol Metab 1985; 60:444-450
6. 6. Van den Berghe G, de Zegher F, Lauwers P, et al: Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: Effect of dopamine. Clin Endocrinol 1994; 41: 563-569
7. 7. Girard K, Raffin TA: The chronically critically ill: To save or let die? Respir Care 1985; 30:339-347
8. 8. Daly BJ, Rudy EB, Thompson KS, et al: Development of a special care unit for chronically critically ill patients. Heart Lung 1991; 20:45-51
9. 9. Clochesy JM, Daly BJ, Montenegro HD: Weaning chronically critically ill adults from mechanical ventilatory support: A descriptive study. Am J Crit Care 1995; 4:93-99
10. 10. Rudy EB, Daly BJ, Douglas S, et al: Patient outcomes for the chronically critically ill: Special care unit versus intensive care unit. Nurs Res 1995; 44:324-331
11. 11. Douglas S, Daly BJ, Rudy EB, et al: Survival experience of chronically critically ill patients. Nurs Res 1996; 45:73-77
12. 12. Villareal DT, Morley JE: Trophic factors in aging: Should older people receive hormonal replacement therapy? Drugs Aging 1994; 4:492-509
13. 13. Orrell RW, Woodrow DF, Barrett MC, et al: Testosterone deficiency myopathy. J R Soc Med 1995; 88:454-456
14. 14. Bagatell CJ, Bremner WJ: Androgens in men: Uses and abuses. N Engl J Med 1996; 334: 707-714
15. 15. Jackson JA, Riggs MW, Spiekerman AM: Testosterone deficiency as a risk factor for hip fractures in men: A case-control study. Am J Med Sci 1992; 304:4-8
16. 16. Scheinhorn DJ, Artinian BM, Catlin JL: Weaning from prolonged mechanical ventilation: The experience at a regional weaning center. Chest 1994; 105:534-539
17. 17. Winters SJ: Endocrine evaluation of testicular function. Endocrinol Metab Clin North Am 1994; 23:709-723
18. 18. Griffin JE, Wilson JD: Disorders of the testes and the male reproductive tract. In: Williams Textbook of Endocrinology. Eighth Edition. Wilson JD, Foster DW (Eds). Philadelphia, WB Saunders, 1992, pp 799-852
19. 19. Vermeulen A: Clinical review 24: Androgens in the aging male. J Clin Endocrinol Metab 1991; 73:221-224
20. 20. Dunn JF, Nisula BC, Rodbard D: Transport of steroid hormones: Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53:58-68
21. 21. Pugeat MM, Dunn JF, Nisula BC: Transport of steroid hormones: Interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53: 69-75
22. 22. Carter WJ: Effect of anabolic hormones and insulin-like growth factor-1 on muscle mass and strength in elderly persons. Clin Geriatr Med 1995; 11:735-748
23. 23. Korenman SG: Androgen function after age 50 years and treatment of hypogonadism. Curr Ther Endocrinol Metab 1994; 5:585-587
24. 24. Tenover JL: Testosterone and the aging male. J Androl 1997; 18:103-106
25. 25. Reichlin S: Neuroendocrine-immune interactions. N Engl J Med 1993; 329:1246-1253
26. 26. Wilson JD, Griffin JE: The use and misuse of androgens. Metabolism 1980; 29:1278-1295
27. 27. Van den Berghe G, de Zegher F, Bouillon R: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998; 83:1827-1834
28. 28. Lewis MI, Belman MJ: Nutrition and the respiratory muscles. Clin Chest Med 1988; 9:337-348
29. 29. Pichard C, Jeejeebhoy KN: Muscle dysfunction in malnourished patients. Q J Med 1988; 69:1021-1045
30. 30. Albina JE: Nutrition and wound healing. J Parenter Enteral Nutr 1994; 18:367-376
31. 31. Brodsky IG, Balagopal P, Nair KS: Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men: A clinical research center study. J Clin Endocrinol Metab 1996; 81:3469-3475
32. 32. Wang C, Alexander G, Berman N, et al: Testosterone replacement therapy improves mood in hypogonadal men: A clinical research center study. J Clin Endocrinol Metab 1996; 81:3578-3583
33. 33. Jeejeebhoy KN: How should we monitor nutritional support? Structure or function? New Horiz 1994; 2:131-138